Author

Manuel Barreiro de Acosta 1

1 Complejo Universitario de Santiago de Compostela,Santiago de Compostela,Spain

Defining meaningful attributes for the treatment of IBD from patients' perspective

Edouard Louis, Juan Manuel Ramos-Goñi, Jesus Cuervo, Uri Kopylov, Manuel Barreiro de Acosta, Sara McCartney, Greg Rosenfeld, Dominik Bettenworth, Ailsa L Hart, Kerri L. Novak, Xavier Donnet, David Easton, Roberto Saldana, Katja Protze, Eyal Tzur, Gabriela Alperovich, Francesc Casellas Jorda

RESCUE THERAPY WITH ANTI-TNF AGENTS FOR ESTABLISHED POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE. A MULTICENTRE, RETROSPECTIVE, NATIONWIDE STUDY

Eugeni Domenech Morral, Fiorella Cañete, Miriam Mañosa, Ramiro Cruz Gonzalez Sueyro, Sabino Riestra Menéndez, Manuel Barreiro de Acosta, Pilar Nos, Eva Iglesias Flores, Ana Gutierrez Casbas, Raquel Ríos, Luis Bujanda Fernández de Piérola, Carlos Gonzalez Muñoza, Albert Villoria, María José Casanova González, Antonio García He

Real life experience of first line anti-TNF in Crohn´s disease patients in Spain: do we have data to choose between infliximab and adalimumab?

Ignacio Marín-Jiménez, Guillermo Bastida, Ana Fores, Federico Argüelles-Arias, Ignacio Tagarro, Alonso Fernandez, Carmen Montoto Otero, Mariam Aguas, Rocio Ferreiro Iglesias, Olga Merino, Javier Santos Fernandez, Xavier Cortés, Francisco Mesonero Gismero, Manuel Barreiro de Acosta

Item 1 - 3 / 3
1
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK